IL1B and bronchiectasis: Therefore, we aimed to evaluate acute systemic levels of proinflammatory cytokines (IL-17a, IL-1β, IL-8, and tumor necrosis factor alpha (TNF-α)) and high-sensitivity C-reactive protein (hsCRP) during bronchiectasis exacerbations and follow-up (days 30 and 60).